HAEMATO AG

HAEMATO AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.28
Market Cap
EUR113.88 M
Shares Outstanding
22.87 M
Public Float
10.97 M

Profile

Address
Lilienthalstraße 5c
Schönefeld Brandenburg 12529
Germany
Employees -
Website http://haemato.de
Updated 07/08/2019
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments.

Financials

View All

Andrea Grosse
Chairman-Supervisory Board
Marion Braun
Member-Supervisory Board